Biostime hits the right spots with $322m CB debut
Babycare products manufacturer Biostime International Holdings had an equity-linked debut to remember after raising HK$2.5bn ($332m) via a 2019 zero coupon convertible bond on January 14.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts